Deprescribing in Psychiatry

ISBN : 9780190654818

Swapnil Gupta; John Cahill; Rebecca Miller
224 Pages
156 x 235 mm
Pub date
Sep 2019
Send mail

The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term " refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.
Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.
As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.


Chapter 1 Introduction
Chapter 2 Decision making in deprescribing
Chapter 3 Barriers to deprescribing
Chapter 4 Non pharmacological considerations
Chapter 5 Wellness approaches I: Self-determined strategies
Chapter 6 Wellness approaches II: Collaborative strategies
Chapter 7 Process of deprescribing
Chapter 8 Deprescribing antidepressant medications
Chapter 9 Deprescribing antipsychotic medications
Chapter 10 Deprescribing mood stabilizers medications
Chapter 11 Deprescribing benzodiazepine and stimulants
Chapter 12 Conclusions and future directions

About the author: 

Swapnil Gupta, MBBS, MD Assistant Professor, Department of Psychiatry, Yale University School of Medicine;John D. Cahill, BMBS, PhD, , Assistant Professor, Department of Psychiatry, Yale University School of Medicine
Rebecca Miller, PhD, Assistant Professor, Department of Psychiatry, Yale University School of Medicine

The price listed on this page is the recommended retail price for Japan. When a discount is applied, the discounted price is indicated as “Discount price”. Prices are subject to change without notice.